Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Biomolecular NMR Assignments|February 11, 2014
(1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherinVivitri D Prasasty, Mary E Krause, Usman S F Tambunan, et al.American Journal of Physiology. Renal Physiology|September 4, 2015
Do ASARM peptides play a role in nephrogenic systemic fibrosis?Peter S N Rowe, Lesya V Zelenchuk, Jennifer S Laurence, et al.Journal of Stomatology, Oral and Maxillofacial Surgery|July 14, 2019
Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case reportM-J Javelot, J Sergheraert, S Agbo-Godeau, et al.Endocrinology|December 29, 2007
Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYPAline Martin, Valentin David, Jennifer S Laurence, et al.Journal of Pharmaceutical Sciences|February 10, 2009
The role of covalent dimerization on the physical and chemical stability of the EC1 domain of human E-cadherinMaulik Trivedi, R Andrew Davis, Yumna Shabaik, et al.Scientific Reports|February 14, 2018
Carbonate chemistry of an in-situ free-ocean CO2 enrichment experiment (antFOCE) in comparison to short term variation in Antarctic coastal watersJ S Stark, N P Roden, G J Johnstone, et al.Molecular Ecology Resources|May 14, 2011
Isolation and characterization of polymorphic microsatellite loci in muskrat, Ondatra zibethicusS Laurence, A J Bewick, D W Coltman, et al.Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2013
Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challengesEric F Johnson, J Patrick Connick, James R Reed, et al.Tissue Engineering. Part A|March 12, 2015
Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 HomologuesAdam J Mellott, Keerthana Devarajan, Heather E Shinogle, et al.Pageof 12